About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Treatment of Neuroleptic Induced Acute Akathisia With Trazodone

NCT00659919·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

BeerYaakov Mental Health Center

Age

18–70

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients with akathisia according to DSM-IV criteria at least mild akathisia.

You may not be if

Change of pharmacologic regimen 7 days prior to study entry
Significant systemic disease
The presence of chronic akathisia
Patients unable to cooperate

The record

StatusCompleted

PhasePhase 4

Taking part13

StartedNov 2000

UpdatedJun 17, 2008

Conditions

Where1

Beer Yaakov MHC
Beer Yaacov, Israel

Clareo Health | Treatment of Neuroleptic Induced Acute Akathisia With Trazodone